论文部分内容阅读
目的评价金龙胶囊改善肝癌患者经射频消融术后生存质量的临床疗效。方法 76例原发性肝癌患者共分为2组,观察组经射频消融术治疗后另加金龙胶囊,每日3次,每次3粒,术后第3天起服用。对照组除不用金龙胶囊外,其他治疗措施均与治疗组相同。结果观察组有效率为53.84%,对照组有效率为42.86%,两者比较有显著性差异(P<0.05)。结论金龙胶囊具有稳定瘤体,抑制肿瘤发展,提高生存质量,改善症状,增强患者免疫力,减轻射频消融术后的肝脏损伤等作用,是射频消融技术有益的补充,值得在临床上推广和使用。
Objective To evaluate the clinical efficacy of Jinlong Capsule in improving the quality of life of patients with liver cancer after radiofrequency catheter ablation. Methods A total of 76 patients with primary liver cancer were divided into two groups. Patients in the observation group were treated with radiofrequency catheter ablation and treated with Jinlong capsule three times a day for three times daily. The patients were taken on the third day after operation. In addition to the control group without Jinlong capsule, the other treatment measures are the same with the treatment group. Results The effective rate was 53.84% in the observation group and 42.86% in the control group, with significant difference (P <0.05). Conclusions JINLONG capsule can stabilize tumor, inhibit tumor development, improve quality of life, improve symptoms, enhance patient immunity and reduce liver injury after radiofrequency ablation. It is a useful supplement to radiofrequency ablation and is worthy of clinical promotion and use .